Evidence map›Paper›PMID 23932844›Full record

ReviewDrug and alcohol dependence2013

A review of medical and substance use co-morbidities in Central Asian prisons: implications for HIV prevention and treatment.

Panagiotis Vagenas, Lyuba Azbel, Maxim Polonsky, Nina Kerimi, Mirlan Mamyrov, Sergey Dvoryak, Frederick L Altice

Open access · greenAbstract readReview
In one paragraph

Review in Drug and alcohol dependence, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 40 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Opioid epidemic and liver disease.JHEP reports : innovation in hepatology · 2019
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Public health and international drug policy.Lancet (London, England) · 2016
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Panagiotis Vagenas *Yale School of Medicine, Section of Infectious Diseases, AIDS Program, New Haven, CT, USA.
Lyuba Azbel *Yale School of Medicine, Section of Infectious Diseases, AIDS Program, New Haven, CT, USA.
Maxim PolonskyYale School of Medicine, Section of Infectious Diseases, AIDS Program, New Haven, CT, USA.
Nina KerimiUnited Nations Office on Drugs and Crime (UNODC), Regional Office for Central Asia, Tashkent, Uzbekistan.
Mirlan MamyrovUnited Nations Office on Drugs and Crime (UNODC), Regional Office for Central Asia, Tashkent, Uzbekistan.
Sergey DvoryakUkrainian Institute on Public Health Policy, Kyiv, Ukraine.
Frederick L AlticeYale School of Medicine, Section of Infectious Diseases, AIDS Program, New Haven, CT, USA.
Yale University · USInterstate Commission for Water Coordination of Central Asia · UZUkrainian Institute of Public Health Policy · UA

Funding

Using Coincidence Analysis to Investigate Factors Affecting PrEP Initiation and Continuation in Southern ending the Epidemic CountiesP30MH062294 · NIMH · YALE UNIVERSITY · PI John Edward Pachankis · 2001 to 2026
$48.5M
Prison Interventions and HIV Prevention CollaborationR01DA029910 · NIDA · YALE UNIVERSITY · PI FREDERICK LEWIS ALTICE · 2010 to 2026
$7.9M
Enhancing Health Outcomes Among HIV+ Substance AbusersK24DA017072 · NIDA · YALE UNIVERSITY · PI ALTICE, FREDERICK LEWIS · 2003 to 2012
$1.5M
NIDA NIH HHS K24 DA017072NIDA NIH HHS R01 DA029910NIDA NIH HHS R01DA029910NIMH NIH HHS P30 MH062294
6 · The paper itself

Abstract

backgroundHIV incidence in Central Asia is rising rapidly. People who inject drugs (PWIDs) contribute greatest to the epidemic, with more than a quarter of all HIV cases being in the criminal justice system (CJS). This review assembled and aggregated recent data on drug-related health problems and respective healthcare services in the CJS of Central Asia and the Republic of Azerbaijan.

methodsOnline databases and published literature (peer-reviewed and gray) were reviewed. Additionally, prison officials in the 6 countries were invited to participate in a survey and prison administrators from Kazakhstan, Kyrgyzstan and Tajikistan completed it.

resultsThe data on conditions and healthcare in Central Asian prisons are inconsistent and lack unbiased details. Reporting is primarily based on "official" disease registries, which markedly underestimate prevalence. Even these limited data, however, indicate that HIV prevalence and drug-related health problems are high, concentrated and, in some countries, rising rapidly in CJS. Only some of the range of HIV prevention interventions recommended by international organizations have been implemented in the region with two of the crucial interventions, needle and syringe exchange programs (NSP) and opioid substitution therapy (OST), only available in prisons in Kyrgyzstan, with Tajikistan implementing a pilot NSP and contemplating introduction of prison-based OST.

conclusionsDespite deficiencies in routine health reporting and insufficient HIV sentinel surveillance undertaken in prisons, the data available on the concentration of HIV within at-risk populations in prisons indicate a necessity to broaden the range and increase the scale the scale of HIV prevention and treatment services.

Indexed as

PrisonsAsiaComorbidityHIV InfectionsHumansNeedle-Exchange ProgramsPrevalencePrisonersSubstance Abuse, IntravenousSubstance-Related DisordersAddictionCentral AsiaHIVHIV preventionInjection drug usePrisonersRepublic of AzerbaijanSubstance use disordersTuberculosis

Identifiers

PMID23932844
PMCPMC3825758
OpenAlexW2128533794

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.